Indications 

1. For the treatment of sensitive Gram-negative bacteria such as Escherichia coli, Klebsiella spp, Enterobacter spp, Proteus, Serratia, Pseudomonas aeruginosa and methicillin-sensitive strains of Staphylococcus aureus caused a serious infection, such as septicemia, lower respiratory infections, intestinal infections, pelvic infections, intra-abdominal infections, skin and soft tissue infections, complicated urinary tract infections. Of intra-abdominal infection and pelvic infection should be combined with anti-anaerobic drugs in clinical use more gentamicin in combination with other antimicrobial agents. With penicillin (or ampicillin) combined treat Enterococcus infection.

2. For sensitive central nervous system infections caused by bacteria, such as meningitis, intraventricular inflammation, it can at the same time the FDA intrathecal injection as adjuvant therapy.

Adverse reactions 

1. Tinnitus or other ear ear satiety toxicity, affecting vestibular function may occur gait instability, dizziness. Hematuria may also occur, a significant reduction in frequency of urination or decreased urine output, loss of appetite, extreme thirst and other renal toxicity. There is a result of lower incidence of neuromuscular blockade or renal toxicity caused by difficulty in breathing, lethargy, weakness and so on. Occasional rash, nausea, vomiting, liver dysfunction, leukopenia, neutropenia, anemia, low blood pressure and so on. 

2. Can occur after stopping a small number of patients with hearing loss, tinnitus, or ear ototoxicity full flu symptoms, they should attract attention. 

3. Systemic administration of intrathecal injection of the merger may cause leg cramps, skin rash, fever and generalized convulsions. 

Taboo 

For this product or any other aminoglycoside allergy banned.

Sinder – Your Trusted Source

Sinder Technology is pioneering animal health solution for livestock and poultry breeding industry, and for over 30 years, it has become a professional supplier of Veterinary Drug products supplying a wide range of Vaccine, Transfer Factor, Chicken Egg Yolk Antibody, Feed Additive, Preparation, Raw Material etc, to specialty and proprietary products. Sinder has established world-class manufacturing and development facility, owns dedicated and GMP production lines for cutting-edge manufacturing, and it is performed strictly under adherence to GMP standards. The manufacturing capabilities can act as a growth engine through proprietary innovative products, contract manufacturing and private labelling.

Sinder and its headquarters are GMP Certified and the flagship product Transfer Factor, Chicken Egg Yolk Antibody, LDT3-A, H5N1 and H9 Subtype Vaccine allow us to focus on giving today's informed customers what they want most to maintain a healthy care for livestock and poultry, which have enjoyed great popularities from customers at home and abroad.

Sinder is committed to executing a growth strategy in an attractive industry with 5 core initiatives: Build Premium Brand, Lead Innovation, Expand Channel & Geographic Footprint, Pursue Acquisitions, Drive World-Class Operations.

If you need an edge in your product line, Sinder is your answer. Sinder's mission is to meet your ultimate satisfaction through innovative products and superior services.

Focused on quality for over 30 years, Sinder's headquarters and award-winning manufacturing and development facilities are based in Shandong and Beijing.